LIGAND PHARMACEUTICALS INCORPORATED Cash and Cash Equivalents
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Cash and Cash Equivalents of $1.01 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-07
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.01B.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $115.08M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $174.93M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $139.38M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $1.01B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $115.08M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $174.93M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $139.38M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $67.67M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $47.99M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $72.31M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $63.62M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $18.14M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $50.09M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $22.95M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $19.27M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $28.45M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $88.73M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $45.01M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $4.12M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $5.28M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.99M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $19.52M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $23.43M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $21.86M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $31.85M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $47.62M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $456.92M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $115.16M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $117.53M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $71.54M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $225.30M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $273.05M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $105.11M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $117.16M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $115.56M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $151.46M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $51.02M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $20.62M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $32.74M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $60.22M 10-Q · filed 2018-08-08 | |
| 2017-03-31 | $10.64M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $18.75M 10-Q · filed 2018-08-08 | |
| 2016-09-30 | $86.58M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $61.35M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $31.29M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $97.43M 10-K · filed 2018-03-01 | |
| 2015-09-30 | $93.77M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $108.24M 10-Q · filed 2016-11-14 | |
| 2015-03-31 | $165.77M 10-Q · filed 2016-11-14 | |
| 2014-12-31 | $160.20M 10-K · filed 2018-03-01 | $11.64M 10-K · filed 2014-12-01 |
| 2014-09-30 | $180.66M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $14.54M 10-Q · filed 2015-08-05 | $14.54M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $12.98M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $11.64M 10-K · filed 2017-02-28 | |
| 2013-09-30 | $3.27M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | $5.92M 10-Q · filed 2014-08-05 | |
| 2013-03-31 | $5.04M 10-Q · filed 2014-05-07 | |
| 2012-12-31 | $12.38M 10-K · filed 2016-11-14 | |
| 2012-09-30 | $7.05M 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $8.88M 10-Q · filed 2013-08-01 | |
| 2012-03-31 | $9.78M 10-Q · filed 2013-05-08 | |
| 2011-12-31 | $7.04M 10-K · filed 2015-02-23 | |
| 2011-09-30 | $2.25M 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $3.44M 10-Q/A · filed 2012-11-14 | |
| 2011-03-31 | $6.03M 10-Q/A · filed 2012-11-14 | |
| 2010-12-31 | $3.35M 10-K/A · filed 2014-12-12 | |
| 2010-09-30 | $3.80M 10-Q/A · filed 2012-02-10 | |
| 2010-06-30 | $3.23M 10-Q/A · filed 2012-02-10 | |
| 2009-12-31 | $16.03M 10-K · filed 2013-03-14 | |
| 2008-12-31 | $28.75M 10-K/A · filed 2012-11-14 |